Drug Shortage Report for ESTRING

Last updated on 2025-04-30 History
Report ID 201581
Drug Identification Number 02168898
Brand name ESTRING
Common or Proper name Estring
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ESTRADIOL
Strength(s) 2MG
Dosage form(s) RING (SLOW-RELEASE)
Route of administration VAGINAL VAGINAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1ea
ATC code G03CA
ATC description ESTROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-08-10
Estimated end date
Actual end date 2025-04-29
Shortage status Resolved
Updated date 2025-04-30
Company comments For more information: Paladin Toll Free: 1-866-340-1112 Paladin Fax: 1-866-340-7221 Email: [email protected]
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2025-04-30 English Compare
v30 2025-04-29 French Compare
v29 2025-04-29 English Compare
v28 2025-04-29 English Compare
v27 2025-03-11 French Compare
v26 2025-03-11 English Compare
v25 2025-02-03 French Compare
v24 2025-02-03 English Compare
v23 2024-11-14 French Compare
v22 2024-11-14 English Compare
v21 2024-09-10 French Compare
v20 2024-09-10 English Compare
v19 2024-06-07 French Compare
v18 2024-06-07 English Compare
v17 2024-04-24 French Compare
v16 2024-04-24 English Compare
v15 2024-03-13 French Compare
v14 2024-03-13 English Compare
v13 2024-03-13 English Compare
v12 2024-01-12 French Compare

Showing 1 to 20 of 31